Medical treatment after myocardial infarction

References

• Dellborg M, Eriksson P, Riha M, et al. Declining hospital mortality in acute myocardial infarction. Circulation 1991: 84(4): II334
   Google Scholar
• Lesch M. Post myocardial infarction risk stratification: 1991 perspective. Henry Ford Hosp Med J 1991: 39(3–4): 265–71
   PubMedGoogle Scholar
• DeBusk RF, Blomqvist CG, Kouchoukos NT, et al. Identification and treatment of low- risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med 1986: 314(3): 161–6
   PubMed Web of Science ®Google Scholar
• Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990: 322(11): 743–53
   PubMed Web of Science ®Google Scholar
• Weber KT, Janicki JS, Russell RO, et al. Identification of high risk subsets of acute myocardial infarction: derived from the myocardial infarction research units cooperative study data bank. Am J Cardiol 1978: 41 (2): 197–203
   PubMed Web of Science ®Google Scholar
• Bigger JT, Heller CA, Wenger TL, et al. Risk stratification after acute myocardial infarction. Am J Cardiol 1978: 42(2): 202–10
   PubMed Web of Science ®Google Scholar
• Bigger JT Jr. New directions and new uses for risk stratification in the posthospital phase of acute myocardial infarction. Am J Med 1979: 67(1): 1–2
   PubMed Web of Science ®Google Scholar
• Moss AJ. Factors influencing prognosis after myocardial infarction. Curr Probl Cardiol 1979: 4(5): 6–53
   PubMedGoogle Scholar
• MOM AJ, Bigger JT Jr, Odoroff CL. Postinferct risk stratification. Prog Cardiovasc Dis 1987: 29(6): 389–412
   PubMedGoogle Scholar
• The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983: 309(6): 331–6
   PubMed Web of Science ®Google Scholar
• Starling MR, Crawford MH, Kennedy GT, et al. Exercise testing early after myocardial infarction: predictive value for subsequent unstable angina and death. Am J Cardiol 1980: 46(6): 909–14
   PubMed Web of Science ®Google Scholar
• Murray DP, Murray RG, Rafiqi E, et al. Routine exercise testing or thallium-201 scintigraphy for prediction of cardiac events post-myocardial infarction? Eur J Nud Med 1987: 13(6): 274–7
   PubMedGoogle Scholar
• Ryan T, Armstrong WF. O'Donnell JA, et al. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987: 114(6): 1305–16
   PubMed Web of Science ®Google Scholar
• Candell-Riera J, Permanyer-Miralda G, Castell J, et al. Uncomplicated first myocardial infarction: strategy for comprehensive prognostic studies. J Am Coll Cardiol 1991: 18(5): 1207–19
   PubMed Web of Science ®Google Scholar
• Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985: 27(5): 335–71
   PubMed Web of Science ®Google Scholar
• Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988: 260(14): 2088–93
   PubMed Web of Science ®Google Scholar
• Yusuf S, Furberg CD. Effects of calcium channel blockers on survival after myocardial infarction. (Editorial) Cardiovasc Drugs Ther 1987: 1(4): 343–4
   PubMedGoogle Scholar
• Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized, multicenter trial. N Engl J Med 1986: 315(7): 423–9
   PubMed Web of Science ®Google Scholar
• The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988: 319(7): 385–92
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N EnglJ Med 1988: 319(2): 80–6
   PubMed Web of Science ®Google Scholar
• Sharpe N, Smith H, Murphy J, et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet 1991: 337(8746): 872–6 [erratum, Lancet 1991: 337(8750): 1174]
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992: 327(10): 669–77
   PubMed Web of Science ®Google Scholar
• Chalmers TC, Matta RJ, Smith H Jr, et al. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med 1977: 297(20): 1091–6
   PubMed Web of Science ®Google Scholar
• Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990: 323(3): 147–52
   PubMed Web of Science ®Google Scholar
• Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction: ISIS (International Studies of Infarct Survival) pilot study. Eur Heart J 1987: 8(6): 634–42
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988: 296(6618): 320–31
   PubMedGoogle Scholar
• The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988: 148(1): 36–69
   PubMed Web of Science ®Google Scholar
• LaRosa JC, Cleeman JI. Cholesterol lowering as a treatment for established coronary heart disease. Circulation 1992: 85(3): 1229–35
   PubMed Web of Science ®Google Scholar
• Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987: 257(23): 3233–40 [erratum, JAMA 1988: 259(18): 2698]
   PubMed Web of Science ®Google Scholar
• Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990: 323(19): 1289–98
   PubMed Web of Science ®Google Scholar
• Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990: 264(23): 3007–12
   PubMed Web of Science ®Google Scholar
• Oldridge NB, Guyatt GH, Fischer ME, et al. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA 1988: 260(7): 945–50
   PubMed Web of Science ®Google Scholar
• O'Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989: 80(2): 23444
   Google Scholar